Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma

Autor:	Hervé Brisse, Matthieu Carton, Christine Levy, Daniel Orbach, Ofira Zloto, Hélène Boutroux, Veronique Minard-Colin, Stéphanie Bolle, Frédéric Kolb, Sylvie Helfre
Rok vydání:	2020
Předmět:	Adult Male medicine.medical_specialty Subsequent Relapse Adolescent medicine.medical_treatment Brachytherapy Antineoplastic Agents Disease-Free Survival Metastasis Refractory Antineoplastic Combined Chemotherapy Protocols Rhabdomyosarcoma medicine Humans Child Retrospective Studies Chemotherapy Radiotherapy business.industry Infant Retrospective cohort study General Medicine medicine.disease Combined Modality Therapy Confidence interval Surgery Radiation therapy Ophthalmology Child Preschool Orbital Neoplasms Female Neoplasm Recurrence Local business
Zdroj:	Acta ophthalmologicaReferences. 99(3)
ISSN:	1755-3768
Popis:	OBJECTIVE Localized orbital rhabdomyosarcoma (oRMS) has an overall favourable prognosis with more than 90% of survival. Little is known about the best strategy in recurrent/refractory (R/R) cases. The purpose is to examine the characteristics of patients with R/R-oRMS, focusing on local therapy. METHODS This is bicentric retrospective study. Analysis is of young patients (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d87145f5505147f7785392fe985058c https://pubmed.ncbi.nlm.nih.gov/32833335 Zobrazit plný text záznamu Plný text